AAAAAA

   
Results: 1-7 |
Results: 7
Identification and characterization of human deoxyguanosine kinase cDNA fragments
Authors: Mansson, E Jonsson, K Albertioni, F
Citation: E. Mansson et al., Identification and characterization of human deoxyguanosine kinase cDNA fragments, CANCER LETT, 170(2), 2001, pp. 147-152
Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy
Authors: Mansson, E Paul, A Lofgren, C Ullberg, K Paul, C Eriksson, S Albertioni, F
Citation: E. Mansson et al., Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy, BR J HAEM, 114(3), 2001, pp. 557-565
Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide
Authors: Lotfi, K Mansson, E Chandra, J Wang, YY Xu, DW Knaust, E Spasokoukotskaja, T Liliemark, E Eriksson, S Albertioni, F
Citation: K. Lotfi et al., Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide, BR J HAEM, 113(2), 2001, pp. 339-346
Arylacetamides as peripherally restricted kappa opioid receptor agonists
Authors: Kumar, V Marella, MA Cortes-Burgos, L Chang, AC Cassel, JA Daubert, JD DeHaven, RN DeHaven-Hudkins, DL Gottshall, SL Mansson, E Maycock, AL
Citation: V. Kumar et al., Arylacetamides as peripherally restricted kappa opioid receptor agonists, BIOORG MED, 10(22), 2000, pp. 2567-2570
Biochemical pharmacology and resistance to 2-chloro-2 '-arabinonuoro-2 '-deoxyadenosine, a novel analogue of cladribine in human leukemic cells
Authors: Lotfi, K Mansson, E Spasokoukotskaja, T Pettersson, B Liliemark, J Peterson, C Eriksson, S Albertioni, F
Citation: K. Lotfi et al., Biochemical pharmacology and resistance to 2-chloro-2 '-arabinonuoro-2 '-deoxyadenosine, a novel analogue of cladribine in human leukemic cells, CLIN CANC R, 5(9), 1999, pp. 2438-2444
Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity
Authors: Dehaven-Hudkins, DL Burgos, LC Cassel, JA Daubert, JD Dehaven, RN Mansson, E Nagasaka, H Yu, G Yaksh, T
Citation: Dl. Dehaven-hudkins et al., Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity, J PHARM EXP, 289(1), 1999, pp. 494-502
Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line
Authors: Mansson, E Spasokoukotskaja, T Sallstrom, J Eriksson, S Albertioni, F
Citation: E. Mansson et al., Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line, CANCER RES, 59(23), 1999, pp. 5956-5963
Risultati: 1-7 |